TherapeuticsMD (TXMD) Accumulated Expenses (2011 - 2026)
TherapeuticsMD's (TXMD) quarterly Accumulated Expenses came in at $2.2 million in Q1 2026, up 1627.91% YoY from $129000.0 in Q1 2025, and up 28.03% on a QoQ basis from $1.7 million in Q4 2025.
TherapeuticsMD (TXMD) Accumulated Expenses (2011 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 16 years of Accumulated Expenses data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Accumulated Expenses rose 1627.91% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 1627.91% YoY) and the FY2025 annual result came in at $1.7 million, down 18.15% from the prior year.
- Accumulated Expenses advanced to $2.2 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $18.8 million in Q4 2022 to a low of $129000.0 in Q1 2025.
- A 5-year average of $3.4 million and a median of $2.1 million in 2024 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Accumulated Expenses sank 95.96% — and 2026, when it surged 1627.91%.
- Tracing TXMD's Accumulated Expenses over 5 years: stood at $18.8 million in 2022, then slumped by 95.96% to $762000.0 in 2023, then soared by 179.13% to $2.1 million in 2024, then dropped by 18.15% to $1.7 million in 2025, then advanced by 28.03% to $2.2 million in 2026.
- The last three Accumulated Expenses figures came in at $2.2 million (Q1 2026), $1.7 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | TherapeuticsMD | 23.78 Mn | 14.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.88 Mn |
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 1.59 Mn |
| Mar 31, 2025 | 129,000.00 |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 2.68 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 762,000.00 |
| Dec 31, 2022 | 18.85 Mn |
| Dec 31, 2021 | 44.30 Mn |
| Sep 30, 2021 | 51.67 Mn |
| Jun 30, 2021 | 51.11 Mn |
| Mar 31, 2021 | 45.97 Mn |
| Dec 31, 2020 | 38.17 Mn |
| Sep 30, 2020 | 2.56 Mn |
| Jun 30, 2020 | 2.28 Mn |
| Mar 31, 2020 | 893,332.00 |